Relative to its peers, ENMD does not have very much institutional sponsorship. The 12.37% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 56.00 shares of EntreMed Inc